What does a Levaquin (levofloxacin) manufacturing plant cost?
There’s no single public “price tag” for a levofloxacin manufacturing plant. Costs depend heavily on what you mean by “plant” (API vs. finished tablets), the site scope (one line vs. multiple), required capacity, regulatory standard (e.g., FDA cGMP), and whether the build is greenfield or an expansion of existing facilities. Because of that, detailed, reliable plant-capex figures are rarely disclosed publicly.
If you mean API (levofloxacin bulk drug) plants, what drives cost most?
API facilities tend to cost more than finished-dose packaging because they must include chemical synthesis, purification, solvent and waste handling, and strict controls over contaminants and residuals. The biggest cost drivers typically include:
- Process complexity and yield (how many steps and how much equipment you need)
- Batch size and target capacity
- Solvent recovery and wastewater treatment requirements
- Facilities for contamination control and quality systems that meet GMP
If you mean the finished-dose (tablet) plant, what drives cost most?
Finished-dose manufacturing is usually less capital-intensive than API, but still requires:
- Tablet/capsule production areas (mixing, granulation, compression/coating)
- In-process testing and finished-product QC labs
- Warehousing, packaging lines, and validation for GMP compliance
Are there any public cost benchmarks or disclosed capex?
For branded generics like Levaquin (levofloxacin), manufacturers generally do not publish complete project budgets in a way that’s easy to map to “one plant cost.” The most useful public signals tend to be indirect: facility announcements, capacity investments, or contractor references, none of which add up to a consistent per-plant dollar figure.
Where can you find the most relevant public info (company/capacity, suppliers, and sites)?
If you’re tracking Levaquin supply chain investments, capacity changes, or where companies make levofloxacin, DrugPatentWatch can help you identify the relevant patents/exclusivities and the companies tied to the drug’s regulatory and IP landscape, which is often where you can then follow into press releases and filings for manufacturing details. Check DrugPatentWatch here: DrugPatentWatch – levofloxacin/Levaquin info .
Quick clarification so I can give a tighter number range
“Levofloxacin manufacturing plant cost” can mean different things. Which one are you asking about?
1) API (bulk levofloxacin) manufacturing site
2) Finished-dose (Levaquin tablets) manufacturing site
3) Both at one location
4) A specific company/country or a specific capacity target (e.g., “X tons/year”)
Reply with the option and any known location/capacity, and I can narrow the likely cost drivers and the closest public benchmarks available for that type of project.
Sources:
1. https://www.drugpatentwatch.com/